Organization · Fund of Funds

Ask Yggdrasil Venture Capital

Ask Yggdrasil Venture Capital is a Denmark-based fund-of-funds that invests in venture capital funds across the Americas and Europe, focusing on biotech, pharmaceutical, and technology sectors.

Fund of FundsFunderAllocator

Overview

What Ask Yggdrasil Venture Capital does

What Ask Yggdrasil Venture Capital is

Ask Yggdrasil Venture Capital is a Denmark-based fund-of-funds that invests in venture capital funds across the Americas and Europe, focusing on biotech, pharmaceutical, and technology sectors.

How it participates in the startup ecosystem

The current public profile supports funder and allocator capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.

Operational profile

Organization status and context

Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.

Operational status
Active
Organization type
Fund of Funds
Structured capabilities
Funder · Allocator
Last reviewed
April 9, 2026

Official channels

Find Ask Yggdrasil Venture Capital elsewhere

Open the official website or a supported primary organization account.

Capability profile

Ask Yggdrasil Venture Capital as a funder

Investment thesis

Ask Yggdrasil Venture Capital focuses on identifying unique venture capital fund opportunities to create a highly diversified portfolio.

Focus narrative

The firm invests in the biotech, pharmaceutical, and technology sectors through a fund-of-funds structure. By targeting early-stage investments, Ask Yggdrasil Venture Capital seeks to leverage the expertise of its underlying fund managers to identify promising opportunities across the Americas and Europe.

Value beyond capital

Ask Yggdrasil Venture Capital adds value by providing access to a diversified portfolio of venture capital funds, allowing investors to benefit from a broad range of opportunities while minimizing risk associated with individual startups.

Focus and fit

Stages
Pre-seed · Seed · Series A · Series B · Series C · Series D
Regions
Europe

Availability

Currently deploying
Not published

Capability profile

Ask Yggdrasil Venture Capital as an allocator

Allocator mandate

Ask Yggdrasil Venture Capital invests in the biotech, pharmaceutical, and technology sectors. They access venture capital funds across the Americas and Europe, targeting early-stage investments from pre-seed to series A-D.

Focus narrative

Ask Yggdrasil Venture Capital is a venture capital firm that focuses on identifying unique venture capital fund opportunities. The organization aims to create a highly diversified portfolio by investing in various sectors.

Value and partnership

The model is designed to maximize diversification and mitigate single-company risk by allocating capital to VC funds rather than directly to startups.

Availability and engagement

Direct co-investment
No

Mandate and fit

Fund stages
Seed Funds · Early Stage
Asset classes
Venture
Regions
Americas · Europe

Connected ecosystem

Continue from Ask Yggdrasil Venture Capital

These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.

Common questions

What to know about Ask Yggdrasil Venture Capital

Upseed classifies Ask Yggdrasil Venture Capital under the Fund of Funds organization type. Its current public profile includes funder and allocator capabilities.

Next step

Keep comparing startup organizations

Return to the organization index or continue through a verified sector, place, peer, or program connected to this profile.

Source and update disclosure

Know what this page is based on

Source basis

Public organization and program material, official websites, and structured Upseed records.

Last reviewed

April 9, 2026

Known limits

Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.

Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.